| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $4,613,217 ) |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01CA167551 | Colon Cancer Family Registry Cohort | 001 | 15 | NIH | 5/12/2026 | $205,018 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01AI180165 | REINVIGORATE: Repeated Enhanced INfluenza Vaccines In Geriatrics of a Randomised trial for Antibody and T cell Effects | 000 | 3 | NIH | 3/30/2026 | $355,813 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01DK135122 | Characterizing the evolution of impaired hypoglycemia awareness in people with type 1 diabetes and the impact of automated insulin delivery and exercise on restoring hypoglycemia awareness | 001 | 4 | NIH | 8/14/2026 | $377,631 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01DK135122 | Characterizing the evolution of impaired hypoglycemia awareness in people with type 1 diabetes and the impact of automated insulin delivery and exercise on restoring hypoglycemia awareness | 000 | 4 | NIH | 8/4/2026 | $186,369 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 010 | 6 | NIH | 8/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 009 | 6 | NIH | 8/7/2026 | $91,174 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 008 | 6 | NIH | 7/31/2026 | $208,804 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 007 | 6 | NIH | 7/24/2026 | $400,977 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 006 | 6 | NIH | 7/17/2026 | $231,552 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 004 | 6 | NIH | 7/7/2026 | $86,975 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 003 | 6 | NIH | 6/23/2026 | $189,465 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 002 | 6 | NIH | 6/23/2026 | $383,213 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 001 | 6 | NIH | 6/9/2026 | $1 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | R01HD121632 | De-risking therapeutic use in the context of lactation by coupling perturbation studies and machine learning | 000 | 1 | NIH | 6/23/2026 | $562,250 |
| | 2026 | 2026 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01CA167551 | Colon Cancer Family Registry Cohort | 000 | 15 | NIH | 4/27/2026 | $1,538,974 |
| | 2026 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 005 | 5 | NIH | 7/15/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 005 | 5 | NIH | 7/15/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 005 | 5 | NIH | 7/15/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 000 | 5 | NIH | 3/9/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 000 | 5 | NIH | 3/9/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01DK131384 | Building a multi-scale vascular atlas of the mouse lower urinary tract | 001 | 5 | NIH | 7/8/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01DK131384 | Building a multi-scale vascular atlas of the mouse lower urinary tract | 000 | 5 | NIH | 5/15/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 000 | 5 | NIH | 3/9/2026 | $0 |
| | 2026 | 2024 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | R01AI148407 | Investigating the basis of MAIT cell antigen potency | 000 | 5 | NIH | 1/28/2026 | $0 |
| | 2026 | 2023 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | R01AI141534 | Does repeated influenza vaccination constrain influenza immune responses and protection? | 000 | 5 | NIH | 12/18/2025 | -$64,861 |
| | 2026 | 2022 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | R01AG058676 | Alzheimer's dementia onset and progression in international cohorts (Amended) | 000 | 5 | NIH | 12/1/2025 | -$140,138 |
|
| Issue Date FY: 2025 ( Subtotal = $7,698,569 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01CA167551 | Colon Cancer Family Registry Cohort | 002 | 14 | NIH | 4/2/2025 | $1,618,142 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01DK143330 | The Evaluation of Two Response Thresholds to Continuous Ketone Monitoring Information Minimising Ketosis in People with Type 1 Diabetes Treated with Sotagliflozin. | 000 | 1 | NIH | 9/11/2025 | $987,196 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | R01AI194343 | Direct and Indirect Targeting of HIV Tat for Selective RNA Degradation and Protein Suppression | 000 | 1 | NIH | 9/12/2025 | $394,820 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01AI180165 | REINVIGORATE: Repeated Enhanced INfluenza Vaccines In Geriatrics of a Randomised trial for Antibody and T cell Effects | 000 | 2 | NIH | 8/8/2025 | $355,813 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 007 | 5 | NIH | 8/12/2025 | $31,412 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 005 | 5 | NIH | 8/12/2025 | $9,551 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 003 | 5 | NIH | 8/12/2025 | $8,640 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 007 | 5 | NIH | 8/12/2025 | $53,519 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 004 | 5 | NIH | 8/12/2025 | $29,437 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 003 | 5 | NIH | 8/12/2025 | $8,639 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 002 | 5 | NIH | 8/12/2025 | $67,720 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 000 | 5 | NIH | 8/8/2025 | $2,494,326 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 003 | 5 | NIH | 8/12/2025 | $14,720 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 001 | 5 | NIH | 8/12/2025 | $29,624 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 005 | 5 | NIH | 8/12/2025 | $5,606 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 004 | 5 | NIH | 8/12/2025 | $29,440 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 002 | 5 | NIH | 8/12/2025 | $39,747 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 001 | 5 | NIH | 8/12/2025 | $29,622 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 007 | 5 | NIH | 8/12/2025 | $31,414 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 005 | 5 | NIH | 8/12/2025 | $5,606 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 004 | 5 | NIH | 8/12/2025 | $50,155 |
| | 2025 | 2025 | UNIVERSITY OF MELBOURNE | RAYMOND PRIESTLEY BLDG UNIV OF MELB | MELBOURNE | VICTORIA | | | AUS | U01MH124631 | Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT) | 002 | 5 | NIH | 8/12/2025 | $39,750 |
|
